We are live on ! Find out more
COCH icon

Envoy Medical

28 hedge funds and large institutions have $1.65M invested in Envoy Medical in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more funds holding

Funds holding: 2228 (+6)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.95% less ownership

Funds ownership: 10.81%9.87% (-0.95%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

50% less capital invested

Capital invested by funds: $3.28M → $1.65M (-$1.63M)

Holders
28
Holders Change
+6
Holders Change %
+27.27%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
7
Increased
4
Reduced
6
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
26
Citigroup
New York
$55 +$96 +71 New
Bank of America
27
Bank of America
North Carolina
$5 -$94 -69 -91%
SS
28
SBI Securities
Japan
$1 +$1 +1 New

COCH Hedge Fund Activity: Q3 2025 in Review

28 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2025, worth a combined $1.65M — down 50% from $3.28M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new COCH positions and 0 closed out — a net gain of 7 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Meteora Capital, opening a new position worth an estimated $37.1K. The largest seller was Weiss Asset Management, cutting an estimated $170K.

  • 28 institutional investors held Envoy Medical (COCH) as of Q3 2025, up from 22 in Q2 2025.
  • Funds reported $1.65M of Envoy Medical stock for Q3 2025, down 50% quarter-over-quarter.
  • 7 funds opened new Envoy Medical positions in Q3 2025 and 0 closed out, a net change of +7 holders.
  • The largest Envoy Medical buyer in Q3 2025 was Meteora Capital, an estimated $37.1K added.
  • The largest Envoy Medical seller in Q3 2025 was Weiss Asset Management, an estimated $170K sold.

Based on aggregated 13F filings for Q3 2025.